![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 45751-45754, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology, Mount Sinai School of
Medicine, New York, New York 10029
Received for publication, July 29, 2001, and in revised form, September 24, 2001
The crystal structure of soluble functional
fragments of adenylyl cyclase complexed with G Signaling through heterotrimeric G proteins involves
non-covalent protein-protein interactions. Among the best studied of these is the regulation of adenylyl cyclase by G Materials--
Amino acids and reagents for peptides were from
Bachem. [ Peptide Synthesis--
Peptides were synthesized on an Applied
Biosystem peptide synthesizer (model 431A) and purified by high
pressure liquid chromatography on 1-75% acetonitrile
gradients. Purified peptides were lyophilized and stored at Expression of G Protein Subunits and Adenylyl
Cyclases--
HexaHis Q213L-G Adenylyl Cyclase Assays--
Enzymatic activity was measured by
conversion of [ The Switch II regions of G We next tested the effects of an 18-mer peptide (199) encoding the
Switch I region from G
The Signal Transfer Regions of G
s*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
s
and forskolin, shows three regions of G
s in direct
contact with adenylyl cyclase. The functions of these three regions are
not known. We tested synthetic peptides encoding these regions of
G
s on the activities of full-length adenylyl cyclases 2 and 6. A peptide encoding the Switch II region (amino acids 222-247)
stimulated both adenylyl cyclases 2- to 3-fold. Forskolin synergized
the stimulation. Addition of peptides in the presence of activated
G
s partially inhibited G
s stimulation. Corresponding Switch II region peptides from G
q and
G
i did not stimulate adenylyl cyclase. A peptide
encoding the Switch I region (amino acids 199-216) also stimulated AC2
and AC6. The stimulatory effects of the two peptides at saturating
concentrations were non-additive. A peptide encoding the third contact
region (amino acids 268-286) located in the
3-
5 region,
inhibits basal, forskolin, and G
s-stimulated enzymatic
activities. Since this region in G
s interacts with both
the central cytoplasmic loop and C-terminal tail of adenylyl cyclases
this peptide may be involved in blocking interactions between these two
domains. These functional data in conjunction with the available
structural information suggest that G
s activation of
adenylyl cyclase is a complex event where the
3-
5 loop of
G
s may bring together the central cytoplasmic loop and
C-terminal tail of adenylyl cyclase thus allowing the Switch I and
Switch II regions to function as signal transfer regions to activate
adenylyl cyclase.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
s. (1,
2). There is considerable molecular information about the interactions between G
s and adenylyl cyclase (3). The crystal
structure of the G
s complexed with the functional
fragments of adenylyl cyclase has been solved (4) as has been the
structure of the G
s by itself (5). There is reasonably
good agreement between the mutagenesis studies both on
G
s (6) and on adenylyl cyclase (7, 8) itself and the
contact points observed in the co-crystal structures. Nevertheless,
little is known about the role of these regions in signal transfer from
G
s to adenylyl cyclase. We have previously used peptides
encoding regions of G
to identify the functions of these regions in
transfer of signal from G
to phospholipase C-
(9, 10). Two types
of effects were observed. Some peptides encoding regions known to
directly contact PLC1 were
able to stimulate PLC-
2, and these are thought to encode signal
transfer regions. Other peptides that are also thought to contact
PLC-
were able to inhibit G
stimulation of PLC-
2 but by
themselves had no effect on PLC activity. These regions are termed
general binding domains, which are involved in the protein-protein
interactions and contribute to the overall affinity but by themselves
do not transfer signal information. Since three distinct regions in
G
s interact with adenylyl cyclase we determined which of
these contact sites were involved in signal transfer. For this we
synthesized peptides encoding these regions and tested their ability to
modulate basal G
s and forskolin-stimulated adenylyl cyclase activities.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP was from PerkinElmer Life
Sciences. Tissue culture reagents and fetal calf serum were from
Life Technologies, Inc. Protease inhibitors were from Sigma. All other
reagents were the highest analytical grade that was commercially available.
20 °C,
and each peptide container was filled with nitrogen for long-term
storage. When required peptides were dissolved in water to a final
concentration of 1-3 mM. For each assay peptides stock
solutions were freshly prepared. Identity and purity of the peptides
was verified by mass spectrometry.
s (kind gift of Dr. T. Patel, University of Tennessee) was expressed in JM109 (DE3) cells. The
protein in cell lysates was purified on Ni-NTA columns according to a
protocol kindly provided by the Patel laboratory. This protocol is
essentially similar to the method described by Graziano et
al. (11). AC2 and AC6 were expressed in Hi5 cells by infection
with recombinant baculovirus. Membranes were prepared from infected
cells and used for the assays (12).
-32P]ATP to [32P]cAMP.
AC2 and AC6 assays have been described (13, 14). When required, the
peptides were mixed with adenylyl cyclase containing membranes and held
on ice for 10 min prior to assays. Approximately 1-2 µg of AC2 Hi5
cell membranes and 3-5 µg of AC6 membrane per assay tube were used.
Concentration of activated G
s was 2 µM and
that of forskolin 30 µM. All assays contained a mixture
of proteinase inhibitors. Final concentration of proteinase inhibitors was leupeptin 3.2 µg/ml, aprotinin 2 µg/ml, phenanthroline 1.0 mM, and phenylmethylsulfonyl fluoride 1.0 mM.
The protease inhibitor mixture was always freshly prepared. All
experiments were repeated three or more times with qualitatively
similar results. Typical experiments are shown. Values are means ± S.D. of triplicate determinations.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunits undergo substantial
conformational changes upon exchange of GDP for GTP (15, 16), and the
GDP-bound G
s subunit is known to have at least a 10-fold lower affinity for adenylyl cyclase than the GTP
S bound form (17).
Since the Switch II region is also involved in physical contact with
adenylyl cyclase it appeared likely that this region might be involved
in signal transfer, we synthesized a 26-amino acid peptide encoding the
Switch II region and tested its effect on the stimulation of AC2 and
AC6 expressed in Hi5 cells. The G
s-(222-247)
(Switch II) peptide stimulated both enzymes 2- to 3-fold (Fig.
1,A and B).
Although this stimulation is extensive, it is typically about 30-50%
of that observed with saturating concentrations of activated
G
s under these assay conditions. As controls we used
peptides encoding the Switch II region of G
i (amino
acids 199-224) or G
q (amino acids 204-229). The Switch II regions of G
i or G
q are very similar
to the Switch II region of G
s except for some of the
contact residues and the last Asp in the
2 helix. Neither the
G
i or G
q peptides stimulated either adenylyl cyclase (Fig. 1, A and B). The Switch II
peptide stimulated on top of the forskolin both AC2 and AC6 activities.
Stimulation was about 3-fold while the observed EC50 did
not change. The G
i or G
q peptides also
did not further stimulate the activity in the presence of forskolin
(Fig. 1, C and D). We next tested the effect of
G
s-(222-247) peptide on the
G
s-stimulated activity of AC2 and AC6. In both cases the
G
s-stimulated activity was inhibited by about 30-35%
(Fig. 1, E and F). For neither adenylyl cyclase
did the inhibition reach to a level equal to the stimulation observed
by the peptide alone. Thus although the G
s-(222-247) peptide behaves as a "partial agonist" in a qualitative sense it
does not appear to do so in a strict quantitative sense. The peptides
encoding the G
q or G
i did not affect the
G
s-stimulated activity of either adenylyl cyclase.

View larger version (39K):
[in a new window]
Fig. 1.
Effect of the varying concentrations of
peptides encoding the Switch II regions of
G
s,
G
i, and
G
q on the basal- (top
panels), forskolin-stimulated (middle
panels), and activated
G
s-stimulated activities of AC2
(left panels) and AC6 (right panels)
isoforms. All values are means of triplicate determinations and
coefficient of variance is less than 7%.
s. The Switch I peptide behaved similarly to the Switch II peptide. The peptide by itself stimulated both AC2 and AC6 (Fig. 2, A
and B). As a control we used an 18-mer with the following
substitutions: G206P, I207D, E209K, and K211A. Residue 207 contacts
with adenylyl cyclase, while the 209 and 211 substitutions would
disrupt local conformation. The substituted peptide had no effect on
either AC2 or AC6 activities. The Switch I peptide stimulated both AC2
and AC6 on top of forskolin-stimulated activities (Fig. 2, C
and D). As with the Switch II peptide forskolin does not
appear to shift the position of the peptide concentration-effect curves. The Switch I peptide also inhibited the
G
s-stimulated activity of both AC2 and AC6 by about 30%
(Fig. 2, E and F). Thus the Switch I peptide also
qualitatively behaved as a partial agonist.

View larger version (34K):
[in a new window]
Fig. 2.
Effect of the varying concentrations of
peptide encoding the Switch I region of
G
s on the basal- (top
panels), forskolin-stimulated (middle
panels), and activated
G
s-stimulated activities of AC2
(left panels) and AC6 (right panels)
isoforms. The Switch I peptide encodes region 199-216. As a
control a substituted (G206P, I207D, E209K, and K211A) peptide was
used. All values are means of triplicate determinations and coefficient
of variance is less than 10%.
Since both the Switch I and Switch II peptides stimulated adenylyl
cyclase we tested if the effects of the two peptides were additive.
This was done both in the absence and presence of forskolin. At each
concentration, the peptides were tested individually or in combination
of equal amounts. For AC2, at lower concentrations, the effects of the
peptides were additive, giving the appearance of a left-shifted curve.
However, at saturating concentrations the effects were not additive.
The total stimulation appears to plateau at levels seen with the Switch
I peptide (Fig. 3A). In contrast, for AC6 it appears that the effect of Switch II peptide predominates. Even when both peptides were present the total
stimulation was very similar to that seen with the Switch II peptide
alone (Fig. 3B). In the presence of forskolin, the responses
of both AC2 and AC6 appear to be similar. For both adenylyl cyclase
isoforms the maximal activity plateaus close to what is observed with
the Switch I peptide (Fig. 3, C and D). These
results suggest that there may be complex inter-regulation between
forskolin interactions and G
s interactions with adenylyl
cyclases.
|
We also tested the effects of a peptide encoding amino acids 268-286,
which contains the contact site in the
3-
5 region of
G
s that interacts with both the C-terminal tail as well
as the central cytoplasmic loop of adenylyl cyclase. As a control we
used a peptide where the Trp-277 and -280 were replaced with Arg or
Lys, respectively. This peptide inhibited basal- and
forskolin-stimulated activity by about 30% (Fig.
4, A-D) while it very
substantially (~ 75%) inhibited the G
s-stimulated
activity (Fig. 4, E and F). The effect of this
peptide suggests that it may interact with either the central
cytoplasmic loop or the C-terminal tail and thus inhibit all
activities. The greater extent inhibition of G
s
inhibition may arise because appropriate
3-
5 contact is required to appropriately orient the Switch I and/or Switch II region
to stimulate enzymatic activity.
|
| |
DISCUSSION |
|---|
|
|
|---|
Both the Switch I and Switch II peptides show a stimulatory effect
on basal adenylyl cyclase activity and further stimulation in the
presence of forskolin. This is not entirely surprising, when one
considers the crystal structure. Both the Switch I and II regions of
G
s bind to the region within the
1'-
2' domain of
the C-terminal tail of adenylyl cyclase, and the contact residues are
only a few residues apart. It should be noted though that only a single
residue in Switch I contacts the
1'-
2' region of the cytoplasmic
tail of adenylyl cyclase. Hence we cannot definitively rule out the
possibility that its stimulatory ability arises from its interactions
with regions of the native enzyme that are not present in the crystal
structure. Although one might intuitively expect that there may a
single signal transfer region, this is the second protein in which we
have found multiple signal transfer regions, G
being the other (10).
Thus it is possible that there are built-in redundancies within
signaling components to maximize signal flow.
The Gs
3
5 peptide blocks G
s stimulation, and
to a lesser extent basal- and forskolin-stimulated activities as well.
Since the Gs
3
5 peptide had the interaction residues for both the
central cytoplasmic loop as well as the C-terminal tail of adenylyl
cyclase, we expected it may mimic the effect of forskolin. A reasonable explanation for the observed inhibitory effects is that the peptide binds only to the central cytoplasmic loop or C-terminal tail and thus
prevents them from interacting with one another. We added several
residues on both C-terminal and N-terminal regions of the peptide and
did not see any reduction of the inhibitory effects. Adding more
residues greatly reduced the solubility of the peptide and making
experiments with the longer peptides not feasible.
An intriguing aspect of our findings is that of the combined effects of
the Switch I and Switch II peptides on adenylyl cyclase activities. As
expected at low concentrations the effects of the peptides was additive
for AC2. A different effect was observed for AC6 where the presence of
the Switch II peptide appears to block the effect of the Switch I
peptide (Fig. 3B). Thus it appears that there may be some
differences in the mode of interactions between G
s and
the different adenylyl cyclase isoforms. This is an area that requires
further study in a systematic fashion. In the presence of forskolin the
effects of the Switch I peptide appears to predominate for both AC2 and
AC6 since the activity with saturating concentrations of both peptides
appears to be closer to the activity seen with the Switch I peptide
rather than the Switch II peptide (Fig. 3, C and
D). These results suggest that there may be dynamic
interactions between the forskolin binding sites and the interaction
sites for Switch I and II resulting in preferential interactions of one
or another of the signal transfer regions. Further studies focusing on
the dynamics of the contacts and local conformational changes are
required to critically ascertain the molecular mechanisms involved in
forskolin regulation of interactions of the signal transfer regions of
G
s with adenylyl cyclases.
An interesting question arises from these studies: why have multiple
signal transfer regions if only one is used. One possibility is that
both are used since in the crystal structure residues in both the
Switch I and Switch II region make contact with adenylyl cyclase.
However it should be noted that crystal structure contains only part of
the central cytoplasmic loop of AC5 and the C-terminal tail of AC2 and
hence is not an accurate representation of a native enzyme. Further
structural studies with native proteins should clarify this issue.
Another possibility is that depending on the initial interactions
either the Switch I or Switch II region contacts the adenylyl cyclases
and each of these is capable of inducing the local changes necessary to
activate the enzyme. Thus the G
s-adenylyl cyclase
complex may contain multiple conformational species. Dynamic conformational studies will be needed to sort through these alternative scenarios. Irrespective of the molecule specific details that emerge
from future studies, this study along with our previous on G
(9, 10)
indicate that it is possible to assign distinct functions to the
different regions of G protein subunits that contact their direct
effectors. How the signal transfer regions and the other regions of G
proteins cooperate to achieve reversible signal flow with high
specificity remains to be determined.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Jinrong Li for synthesizing some
of the peptides. We are grateful to Dr. Tarun Patel for providing us
with the HexaHis-activated G
s plasmid and the
purification protocol. We thank the reviewer for very thoughtful
comments that were very useful in revising the paper.
| |
FOOTNOTES |
|---|
* This research was supported by National Institutes of Health Grant DK-38761.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology,
Box 1215, Mount Sinai School of Medicine, One Gustave Levy Place, New
York, NY 10029. Tel.: 212-659-1707; Fax: 212-831-0114; E-mail:
ravi.iyengar@mssm.edu.
Published, JBC Papers in Press, September 28, 2001, DOI 10.1074/jbc.M107191200
| |
ABBREVIATIONS |
|---|
The abbreviation used is: PLC, phospholipase C.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Gilman, A. G. (1987) Annu. Rev. Biochem. 56, 615-650[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Iyengar, R. (1993) FASEB J. 7, 768-775[Abstract] |
| 3. | Berlot, C. H., and Bourne, H. R. (1992) Cell 68, 911-922[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Grishina, G.,
and Berlot, C. H.
(1997)
J. Biol. Chem.
272,
20619-20626 |
| 5. |
Tesmer, J. J.,
Sunahara, R. K.,
Gilman, A. G.,
and Sprang, S. R.
(1997)
Science.
278,
1907-1916 |
| 6. |
Sunahara, R. K.,
Tesmer, J. J.,
Gilman, A. G.,
and Sprang, S. R.
(1997)
Science.
278,
1943-1947 |
| 7. |
Yan, S. Z.,
Huang, Z. H.,
Rao, V. D.,
Hurley, J. H.,
and Tang, W. J.
(1997)
J. Biol. Chem.
272,
18849-18854 |
| 8. |
Zimmermann, G.,
Zhou, D.,
and Taussig, R.
(1998)
J. Biol. Chem.
273,
6968-6975 |
| 9. | Buck, E., Li, J., Chen, Y.-B., Weng, G., Scarlatta, S., and Iyengar, R. (1999) Science 283, 332-336 |
| 10. |
Buck, E.,
and Iyengar, R.
(2001)
J. Biol. Chem.
276,
36014-36019 |
| 11. | Graziano, M. P, Freissmuth, M., and Gliman, A. G. (1991) Methods Enzymol. 195, 192-215[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Pieroni, J. P,
Harry, A.,
Chen, J.-Q.,
Jacobowitz, O,
Magnusson, R. P.,
and Iyengar, R.
(1995)
J. Biol. Chem.
270,
21368-21373 |
| 13. |
Harry, A.,
Chen, Y.-B,
Magnusson, R.,
Iyengar, R.,
and Weng, G.
(1997)
J. Biol. Chem.
272,
19017-19021 |
| 14. |
Chen, Y.-B.,
Harry, A.,
Li, J.,
Smit, M. J.,
Bai, X.,
Magnusson, R.,
Pieroni, J. P.,
Weng, G.,
and Iyengar, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14100-14104 |
| 15. | Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B. (1994) Nature 369, 621-628[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sprang, S. R. (1997) Annu. Rev. Biochem. 66, 639-678[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Dessauer, C. W.,
Scully, T. T.,
and Gilman, A. G.
(1997)
J. Biol. Chem.
272,
22272-22277 |
This article has been cited by other articles:
![]() |
X. Gao, Z. Du, and T. B. Patel Copper and Zinc Inhibit G{alpha}s Function: A NUCLEOTIDE-FREE STATE OF G{alpha}s INDUCED BY Cu2+ AND Zn2+ J. Biol. Chem., January 28, 2005; 280(4): 2579 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yoo, R. Iyengar, and Y. Chen Functional Analysis of the Interface Regions Involved in Interactions between the Central Cytoplasmic Loop and the C-terminal Tail of Adenylyl Cyclase J. Biol. Chem., April 2, 2004; 279(14): 13925 - 13933. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Buck and R. Iyengar Organization and Functions of Interacting Domains for Signaling by Protein-Protein Interactions Sci. Signal., November 18, 2003; 2003(209): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Manganello, J.-S. Huang, T. Kozasa, T. A. Voyno-Yasenetskaya, and G. C. Le Breton Protein Kinase A-mediated Phosphorylation of the Galpha 13 Switch I Region Alters the Galpha beta gamma 13-G Protein-coupled Receptor Complex and Inhibits Rho Activation J. Biol. Chem., January 3, 2003; 278(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Buck, P. Schatz, S. Scarlata, and R. Iyengar Role of Dynamic Interactions in Effective Signal Transfer for Gbeta Stimulation of Phospholipase C-beta 2 J. Biol. Chem., December 13, 2002; 277(51): 49707 - 49715. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |